Croda issues margin warning and sees sales slump as economic headwinds grow
It reported £1.695bn in sales, down more than 18 per cent, while its operating profit dropped to £247.5m, a decline of 44 per cent.
Source: cityam.com
Stay updated with breaking news from Solus Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It reported £1.695bn in sales, down more than 18 per cent, while its operating profit dropped to £247.5m, a decline of 44 per cent.
Croda International Plc reports full year results for 2023, showing a decline in sales and profit. The performance was impacted by destocking and weak macroeconomic conditions.
This acquisition will boost Croda’s total offering across its personal care portfolio, with Solus’ phospholipids to be incorporated into Croda’s skin care and hair care franchises.
European markets pressured by rising rates
Croda International acquires Solus Biotech